Leading global supplier of advanced automation and detection solutions for the world’s leading life science laboratories selects clinivation Global xi to manage its medical products approvals and submissions.
Natick, MA, April 16, 2008 – clinivation, Inc. announced today that Tecan Group Limited (SWF: TECN) has selected the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Management solution.
“Tecan is clearly a leader across three major industries: biopharma, forensics and diagnostics,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer. “We are pleased that Tecan’s senior management has selected Global xi to better achieve corporate-wide visibility for their market clearance operations,” he continued.
Clinivation Global xi software enables medical device and diagnostic companies to sell more products to more countries faster and easier than ever before. Clinivation Global xi is the first complete solution targeted at automating the business processes for market clearance operations worldwide.
About Tecan Group Limited
Tecan Group Limited is a leader in the development, production and distribution of advanced automation and detection solutions for the world’s leading life science laboratories. It specializes in the development, production, distribution and servicing of enabling solutions for the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. The Company has three main markets: the biopharma industry consisting of the pharmaceutical, biotechnology and academic research laboratories; the forensics industry based in law enforcement and government laboratories, and the diagnostics industry, which is comprised of blood banks, hospital laboratories and other reference laboratories and their suppliers. Tecan Group operates through five business units: liquid handling and robotics, detection, sample management, components and services and consumables.
Founded in Switzerland in 1980, the company has over 1100 employees, owns production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2006, Tecan achieved sales of CHF 405.9 million (USD 324.7 million; EUR 258.6 million). The Company is headquartered in Maennedorf, Switzerland.
For more information, please visit www.tecan.com.